Surgery Partners
SGRY
$23.21
0Related headlines
SGRY price trend
Wall Street consensus
Most Wall Street analysts maintain a constructive view on Surgery Partners's 12-month outlook, with a consensus price target around $21.70 and implied upside of -6.5% versus the current price.
Average Target
$21.70
0 analysts
Implied Upside
-6.5%
vs. current price
Analyst Count
—
covering this stock
Price Range
$19 - $24
Analyst target range
SGRY Technical Analysis
Beta
1.91
1.91x market volatility
Max Drawdown
-49.9%
Largest decline past year
52-Week Range
$11-$23
Price range past year
Annual Return
+4.7%
Cumulative gain past year
| Period | SGRY Return | S&P 500 |
|---|---|---|
| 1m | +67.3% | -0.9% |
| 3m | +50.7% | +1.2% |
| 6m | +62.6% | +4.9% |
| 1y | +4.7% | +11.2% |
| ytd | +52.1% | +10.8% |
Bobby - Your AI Investment Partner
Get real-time data, AI-driven personalized investment analysis to make smarter investment decisions
Valuation Analysis: Is SGRY Overvalued?
PE
-25.3x
Latest Quarter
vs. Historical
N/A
5-Year PE Range 17x~59x
vs. Industry Avg
N/A
Industry PE ~N/A*
EV/EBITDA
10.2x
Enterprise Value Multiple